Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Twitter Stock Just Might Rise Back to the $40 Level

By Chris Lau, InvestorPlace Contributor

Twitter stock is up alongside Snap and Facebook but a revenue beat and stronger profits this year may boost its share price.

7 Energy Stocks to Buy on the Resurgence of the Oil Boom

By Chris Lau, InvestorPlace Contributor

Higher oil prices could restart the oil boom resurgence that previously ended years ago. This makes several energy stocks appealing buys now.

At This Point, Only a Very Cold Winter Can Move CHK Stock

By Chris Lau, InvestorPlace Contributor

Warm weather in the last few weeks sent natural gas prices lower and leaving CHK stock in shambles without a lot of hope for improvement.

Acasti Pharma Stock Could Soar Above $3 Soon

By Chris Lau, InvestorPlace Contributor

When Acasti posts Phase 3 trial results, ACST stock could re-visit recent highs. Here's why you should pay attention to the stock now.

Nokia Stock Can Climb to $5.00

By Chris Lau, InvestorPlace Contributor

NOK stock fell sharply in the wake of its Q3 results. But Nokia stock can rally meaningfully as NOK cut its costs and wins more 5G deals.

Load More